- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Urispas, flavoxate
Synonyms :
Flavoxate, flavoxato
Class :
Antispasmodic agent,
Dosage Forms & Strengths
Tablet
100mg
100 - 200
mg
Orally
every 6-8 hours
Tablet
100-200mg orally every 6-8 hours
Dosage Forms & Strengths
Tablet
100mg
<12 years: Safety and efficacy not established
>12 years:100-200mg orally every day for every 6-8 hours
may increase the constipating effect of anticholinergic agents
may diminish the therapeutic effects
may increase the anticholinergic effect
may increase the anti-cholinergic effect
may increase the constipating effect of anticholinergic agents
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may diminish the therapeutic effect
may increase the anti-cholinergic effect
may increase the constipating effect of anticholinergic agents
may increase the toxic effects of anti-cholinergic
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may decrease the therapeutic effect
may decrease the therapeutic effect
may decrease the therapeutic effect
may decrease the therapeutic effect
may decrease the therapeutic effect
it may diminish the therapeutic efficacy when combined with castor oil
may decrease the cholinergic effect of cholinergic agents
Frequency defined:
Blurred vision
Constipation
Drowsiness
Dysuria
Headache
Increased ocular tension
Nervousness
Tachycardia
Vertigo
Abdominal pain
Confusion
Disturbance in ocular accommodation
Dry mouth
Eosinophilia
Hyperpyrexia
Nausea
Palpitation
Urticaria
Vomiting
Pregnancy consideration: B
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient information leaflet
Generic Name: flavoxate
Pronounced: flah-VOX-ate
Why do we use flavoxate?
It is used to treat urinary tract infections